Industry Insights with HDT Bio

Application of LION/repRNA to develop vaccines and therapies for infectious diseases and cancer

This hybrid seminar will provide an introduction to HDT’s technology with the goal of identifying collaborations with Canadian investigators in oncology and infectious disease spaces. D2R is hosting HDT Bio for a hybrid seminar to highlight their cutting-edge work at the intersection of RNA therapeutics and immunology, and to foster dialogue around innovative platform technologies with potential for broad applications in infectious diseases, oncology, and beyond.

The format of the webinar will include a 45-minute presentation from Jesse Erasmus, Director of Virology from HDT Bio, followed by 15 minutes of Q&A. 

Register 

To attend in-person, please email D2R.comms [at] mcgill.ca